Author: Ian Conway

Ian Conway has worked in financial markets for over 30 years as a bond and equity trader, Extel-rated analyst and strategist, and partner of a stockbroking firm. He also founded a financial research company servicing institutional clients prior to writing for and editing Shares magazine. Ian is primarily an income investor although he also buys selected growth stocks. Find him at LinkedIn: Click Here

Gear4Music raises earnings forecast again

Online musical instrument retailer Gear4Music (G4M) has raised its earnings forecasts yet again. Just a month ago the firm increased its FY26 outlook, yet already it sees profits topping its previous estimate. Share price: 318.5p (+2.7%)PE: 13.7xMarket Cap: £67mYield: n/a MEDIUM TERM GUIDANCE ALSO RAISED In its Q3 trading update, Gear4Music said it had seen ‘very strong’ revenue growth through the peak seasonal trading period. Sales for the three months to December were £64.6 million, up 32% on the previous year. In addition, due to disciplined pricing, gross profit rose £5 million to £18.7 million taking the gross margin from…

Read More
DFS raises profit forecast

Shares in furniture retailer DFS (DFS) jumped to a 3-year high after the firm raised its earnings outlook. Strong H1 sales and an increase in margins mean profit for the year to June 2026 will top expectations. Share price: 199p (+6.6%)PE: 13.5xMarket cap: £460mYield: 2.2% MAJOR EARNINGS UPGRADE Sofa seller DFS said first-half sales were expected to be up around 9% on the previous year. As well as an ‘elevated’ order book at the start of the half, the firm saw ‘continued positive order intake’. Both the DFS and Sofology brands registered growth in new orders against strong comparatives and…

Read More
Eagle Eye raises profit forecast

AIM-listed digital marketing firm Eagle Eye Solutions (LON:EYE) announced its FY EBITDA would be above current estimates. The firm said it had delivered ‘strong progress’ and its H1 financial performance was already better than expected. Raising the bar Eagle Eye creates digital solutions for large-scale retailers, allowing them to offer personalised, real-time marketing. In the six months to December 2025, it posted an impressive 29% increase in ARR (annual recurring revenue). ARR for the first half was £42.2 million, more than the firm posted in the whole of its 2024/25 financial year. The figure excludes revenue related to the Neptune…

Read More
Anpario raises 2025 forecasts

AIM-listed animal feed additive firm Anpario (ANP) has lifted its full-year revenue and earnings guidance. The company cited stronger than expected year-end demand, helped by its Bio-Vet product range. Share price: 500p (+4.2%)PE: 16.8xMarket cap: £103mYield: 2.4% OPERATIONAL GEARING Anpario enjoyed stronger than anticipated H2 demand, meaning full year revenue will be around £47.1 million. That’s up 23% on 2024 and compares with the consensus forecast of £45.5 million ahead of today’s announcement. Thanks to the group’s strong operational gearing, operating profit rises faster the more revenue it generates. As a result, EBITDA is seen up 34% at not less…

Read More
Ashtead Technology lifts profit forecast

Subsea services firm Ashtead Technology (AT.) has revealed 2025 trading was better than expected. The shares – which are among the most-shorted in the UK market – jumped 12% on today’s update. Share price: 375p (+12%)PE: 9.7xMarket Cap: £270mYield: 0.4% HIGHER MARGINS Full year revenue is now expected to be £203 million, up 21% and in line with the consensus of £205 million. Trading in the second half was strong, and visibility improved as some delayed projects were mobilised. Moreover, synergies from the Q4 2024 acquisitions of Seatronics and J2 Subsea were ahead of forecasts. Together with a higher margin…

Read More
Christie Group raises guidance again

AIM-listed professional services provider Christie Group (CTG) has raised its 2025 earnings guidance again. Having lifted its forecast in December, the firm now sees profit ‘considerably’ ahead of previous expectations. Thanks to ‘uncharacteristically strong’ billing last month, full-year revenue is now seen above £70 million. Operating profit from continuing operations is now expected to be above £6.5 million against £3.5 million in 2024. Increased profitability The group once again advised on the sale or purchase of more than 1,100 businesses in 2025. However, the average fee on those deals was ‘significantly’ higher than in 2024. Also, the volume of deals…

Read More
RTW Biotech celebrates company buyout

Investment trust RTW Biotech Opportunities (RTW) has marked its second success this month with the takeover of Penumbra. The company is being acquired by Boston Scientific (BSX) at a 19% premium in one of the first deals of 2026. At the end of last week, portfolio company Aktis Oncology (AKTS) completed its IPO on New York’s Nasdaq exchange. Atkis issued 17.7 million shares at $18 to raise 318 million, with the shares closing up 24% at $22.40. Share Price: $2.16 (-2.9%)Latest NAV: $2.45Market Cap: $700mDIscount: 12% HIGH GROWTH POTENTIAL The takeover of Penumbra valued the business at $14.5 billion or…

Read More
Impax Environmental trust offers 100% cash exit

Investment trust Impax Environmental Markets (IEM) will offer investors a 100% cash exit by way of a ‘Continuation Tender Offer’. The offer will be pitched close to NAV (net asset value) which as of 15 January was around 440p/share with debt at book cost. That compares with yesterday’s share price of 407p, which represented a discount of 7.5% to NAV. Following today’s announcement, the shares have added 17p or roughly 4% to 424p. Share Price: 424p (+4.2%)NAV/Share: 440pMarket cap: £807m-7.5%Discount: ‘NO CHOICE’ The board said it had ‘no choice’ but to propose the tender offer after pressure from US activist…

Read More
Genus raises earnings guidance

Animal genetics company Genus (GNS) has revealed 1H trading was ahead of expectations. It now expects pre-tax profit of £50 million for the six months to December 2025, above its previous forecast. That figure excludes a milestone payment from CHinese firm BCA to Genus of $7.5 million (£5.6 million) last month. The group also now sees underlying full-year earnings ‘moderately’ above the top end of market estimates. Another upgrade In November 2025, the company said it expected FY pre-tax profit to be modestly ahead of the mid-point of estimates. At the time the range of estimates was £78 million to…

Read More
Wall STreet banks smash earnings forecasts

Wall street firms Goldman Sachs (GS) and Morgan Stanley (MS) smashed expectations with their Q4 results this week. Both banks were big beneficiaries of increased deal volumes rather than stock trading. Goldman Sachs: $958.5 (+3%)Morgan Stanley: $189 (+4.5%)Market cap: $300bnMarket cap: $300bn TOP ADVISOR Goldman Sachs posted Q4 net profit of $4.4 billion, a record not just for the firm but for Wall Street itself. Quarterly EPS (earnings per share) hit $14.01 against a consensus of $11.69 and EPS of $11.95 a year earlier. There were $5 trillion of deals globally last year, driven by the AI dash-for-cash and lower…

Read More